×
OraSure Technologies SG&A Expenses 2010-2024 | OSUR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OraSure Technologies sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
OraSure Technologies SG&A Expenses 2010-2024 | OSUR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OraSure Technologies sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$204.2B
Stryker (SYK)
$146.7B
Boston Scientific (BSX)
$132.6B
EssilorLuxottica (ESLOY)
$112.1B
Medtronic (MDT)
$110.6B
Haleon (HLN)
$43.7B
Lonza Group Ag (LZAGY)
$42.2B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35.8B
Terumo (TRUMY)
$29.7B
Koninklijke Philips (PHG)
$24.8B
Zimmer Biomet Holdings (ZBH)
$21.9B
Insulet (PODD)
$18.4B
Baxter (BAX)
$17B
Smith & Nephew SNATS (SNN)
$11.1B
BellRing Brands (BRBR)
$10.2B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$6.3B
TG Therapeutics (TGTX)
$5.5B
Haemonetics (HAE)
$4.3B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4.1B
Perrigo (PRGO)
$3.8B
Envista Holdings (NVST)
$3.7B
Neogen (NEOG)
$3.2B
Agios Pharmaceuticals (AGIO)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.7B